VANGUARD GROUP INC - 31 Dec 2025 SCHEDULE 13G/A Report for Tonix Pharmaceuticals Holding Corp Common Stock (TNXP)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Tonix Pharmaceuticals Holding Corp Common Stock
Symbol: TNXP
Shares outstanding: 13,418,426 shares
Disclosed Ownership: 673,605 shares
Ownership: 5%
Form type: SCHEDULE 13G/A
Filing time: 30 Jan 2026, 14:45:57 UTC
Date of event: 31 Dec 2025
Previous filing: 31 Oct 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	5%	673,605	0	79,137	Ashley Grim	Head of Global Fund Administration